Found: 625
Select item for more details and to access through your institution.
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 617, doi. 10.1007/s40264-024-01415-7
- By:
- Publication type:
- Article
Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1348324
- By:
- Publication type:
- Article
The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12388-2
- By:
- Publication type:
- Article
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5573, doi. 10.3390/ijms25115573
- By:
- Publication type:
- Article
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6058, doi. 10.3390/ijms25116058
- By:
- Publication type:
- Article
Hypersensitivity reaction to Abiraterone, successful desensitization protocol in prostate cancer patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 4, p. 777, doi. 10.1177/10781552241234876
- By:
- Publication type:
- Article
Heat stress upregulates arachidonic acid to trigger autophagy in sertoli cells via dysfunctional mitochondrial respiratory chain function.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05182-y
- By:
- Publication type:
- Article
Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1933, doi. 10.3390/cancers16101933
- By:
- Publication type:
- Article
Comparative effectiveness of multiple androgen receptor signaling inhibitor medicines with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a study in the real world.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1324181
- By:
- Publication type:
- Article
Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 511, doi. 10.1007/s40262-023-01340-5
- By:
- Publication type:
- Article
Cardiovascular Toxicity During androgen Deprivation Therapy with Abiraterone Acetate in Prostate Cancer: A Case Report and Literature Review.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 2, p. 194
- By:
- Publication type:
- Article
A Comparison of 68 Ga-PSMA PET/CT-Based Split Renal Function with 99m Tc-MAG3 Renography in Patients with Metastatic Castration-Resistant Prostate Carcinoma Treated with 177 Lu-PSMA.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 6, p. 578, doi. 10.3390/diagnostics14060578
- By:
- Publication type:
- Article
Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e242467, doi. 10.1001/jamanetworkopen.2024.2467
- By:
- Publication type:
- Article
Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 3, p. 253, doi. 10.1007/s00280-023-04629-1
- By:
- Publication type:
- Article
Erste klinische und onkologische Erfahrungen mit der Triplet-Therapie beim „high-volume" metastasierten hormonsensiblen Prostatakarzinom.
- Published in:
- Die Urologie, 2024, v. 63, n. 3, p. 254, doi. 10.1007/s00120-023-02253-8
- By:
- Publication type:
- Article
Does the use of antimicrobials in different periodontal treatment strategies result in better treatment outcomes? – A radiographic analysis.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Emerging roles of ADP-dependent glucokinase in prostate cancer.
- Published in:
- Military Medical Research, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40779-024-00518-7
- By:
- Publication type:
- Article
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01853-3
- By:
- Publication type:
- Article
Prostate Cancer and the Mevalonate Pathway.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2152, doi. 10.3390/ijms25042152
- By:
- Publication type:
- Article
Novel hormonal therapy versus standard of care—A registry-based comparative effectiveness evaluation for mCRPC-patients.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0290833
- By:
- Publication type:
- Article
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 508, doi. 10.3390/cancers16030508
- By:
- Publication type:
- Article
Assessment of the Pharmacokinetics and Pharmacodynamics of Injectable Lidocaine and a Lidocaine-Impregnated Latex Band for Castration and Tail Docking in Lambs.
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 2, p. 255, doi. 10.3390/ani14020255
- By:
- Publication type:
- Article
Amelioration of Dissolution Properties of Abiraterone Acetate via Nano-Sizing Employing High-Speed Homogenization Technique: An Optimization Study.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2024, v. 58, p. S158, doi. 10.5530/ijper.58.1s.15
- By:
- Publication type:
- Article
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6853
- By:
- Publication type:
- Article
Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review).
- Published in:
- Experimental & Therapeutic Medicine, 2024, v. 27, n. 1, p. N.PAG, doi. 10.3892/etm.2023.12321
- By:
- Publication type:
- Article
Anti-Algics in the Therapeutic Response of Breast and Urological Cancers.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 468, doi. 10.3390/ijms25010468
- By:
- Publication type:
- Article
Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1277284
- By:
- Publication type:
- Article
New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193736
- By:
- Publication type:
- Article
First person profile: Patricia M. LoRusso, DO: This researcher and clinician has conducted work in early‐phase trials that has led to the approval of several anticancer agents, all while keeping her focus on the patients she says make these trials possible
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3840, doi. 10.1002/cncr.35121
- By:
- Publication type:
- Article
FDA approves new combined treatment for advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3841, doi. 10.1002/cncr.35122
- Publication type:
- Article
Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1290990
- By:
- Publication type:
- Article
Assessing the Efficacy of Anti-Cancer Drugs on Organoid Models Derived from Prostate Cancer.
- Published in:
- Doklady Biochemistry & Biophysics, 2023, v. 513, p. S96, doi. 10.1134/S1607672923700692
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 6, p. 419, doi. 10.1007/s00280-023-04583-y
- By:
- Publication type:
- Article
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence.
- Published in:
- Current Oncology, 2023, v. 30, n. 12, p. 10311, doi. 10.3390/curroncol30120751
- By:
- Publication type:
- Article
Outcomes and toxicity of oral Fosfestrol in metastatic castration-resistant prostate cancer--a real-world experience.
- Published in:
- Ecancermedicalscience, 2023, v. 17, n. 1588-1650, p. 1, doi. 10.3332/ecancer.2023.1589
- By:
- Publication type:
- Article
Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 12, p. 2198, doi. 10.3390/medicina59122198
- By:
- Publication type:
- Article
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 12, p. 3001, doi. 10.1007/s11095-023-03615-9
- By:
- Publication type:
- Article
β-Arrestin2 promotes docetaxel resistance of castration-resistant prostate cancer via promoting hnRNP A1-mediated PKM2 alternative splicing.
- Published in:
- Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00740-0
- By:
- Publication type:
- Article
Abiraterone, a rare cause of severe perioperative hypokalemia with unusual presentation as aphonia and quadriparesis: a case report.
- Published in:
- Ain Shams Journal of Anesthesiology, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s42077-023-00392-w
- By:
- Publication type:
- Article
Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5273, doi. 10.3390/cancers15215273
- By:
- Publication type:
- Article
Editorial Comment to Bone‐modifying agents are protective for symptomatic skeletal events in radium‐223 treatment.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 11, p. 1034, doi. 10.1111/iju.15288
- By:
- Publication type:
- Article
Causal inferences and real-world evidence: A comparative effectiveness evaluation of abiraterone acetate against enzalutamide.
- Published in:
- PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0293000
- By:
- Publication type:
- Article
A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1220457
- By:
- Publication type:
- Article
Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 19, p. 19414, doi. 10.1002/cam4.6536
- By:
- Publication type:
- Article
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter Cohort.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4809, doi. 10.3390/cancers15194809
- By:
- Publication type:
- Article
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1445, doi. 10.1007/s13402-023-00822-9
- By:
- Publication type:
- Article
A Meta-Analysis of Randomized Clinical Trials Assessing the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 10, p. 9262, doi. 10.3390/curroncol30100669
- By:
- Publication type:
- Article
NEW COMBINATION.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 5, p. 13
- Publication type:
- Article
Real‐world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1205, doi. 10.1111/bjh.18985
- By:
- Publication type:
- Article
Top advances of the year: Genitourinary cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2603, doi. 10.1002/cncr.34907
- By:
- Publication type:
- Article